• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞凋亡在癌症的发生发展及治疗中的作用

Apoptosis in the development and treatment of cancer.

作者信息

Gerl Robert, Vaux David L

机构信息

The Walter and Eliza Hall Institute, 1G Royal Parade, Parkville, Victoria 3050, Australia.

出版信息

Carcinogenesis. 2005 Feb;26(2):263-70. doi: 10.1093/carcin/bgh283. Epub 2004 Sep 16.

DOI:10.1093/carcin/bgh283
PMID:15375012
Abstract

Our somatic cells are born by mitosis and almost all will die by apoptosis, a physiological process of cellular suicide. Cancers can occur when this balance is disturbed, either by an increase in cell proliferation or a decrease in cell death. The goal of cancer therapy is to promote the death of cancer cells without causing too much damage to normal cells. Our knowledge of the mechanisms of apoptosis has enhanced our understanding of how some cancers originate and progress. It has also revealed that existing cancer therapies can work in two ways, by induction of apoptosis as well as by direct toxicity. In some cases resistance to apoptosis may explain why cancer therapies fail. Novel treatments designed to exploit our knowledge of apoptotic mechanisms are under development to promote apoptosis of cancer cells and limit concurrent death of normal cells.

摘要

我们的体细胞通过有丝分裂产生,几乎所有体细胞都会通过细胞凋亡死亡,细胞凋亡是一种细胞自杀的生理过程。当这种平衡受到干扰时,无论是细胞增殖增加还是细胞死亡减少,都可能发生癌症。癌症治疗的目标是促进癌细胞死亡,同时又不会对正常细胞造成太大损害。我们对细胞凋亡机制的了解增进了我们对某些癌症如何发生和发展的认识。这也表明,现有的癌症治疗方法可以通过两种方式起作用,即诱导细胞凋亡和直接产生毒性。在某些情况下,对细胞凋亡的抗性可能解释了癌症治疗失败的原因。旨在利用我们对凋亡机制的认识而设计的新型治疗方法正在研发中,以促进癌细胞凋亡并限制正常细胞的同时死亡。

相似文献

1
Apoptosis in the development and treatment of cancer.细胞凋亡在癌症的发生发展及治疗中的作用
Carcinogenesis. 2005 Feb;26(2):263-70. doi: 10.1093/carcin/bgh283. Epub 2004 Sep 16.
2
Apoptosis signaling in tumor therapy.肿瘤治疗中的细胞凋亡信号传导
Ann N Y Acad Sci. 2004 Dec;1028:150-6. doi: 10.1196/annals.1322.016.
3
Therapeutic targeting of apoptosis pathways in cancer.癌症中细胞凋亡途径的治疗靶向作用。
Curr Opin Oncol. 2008 Jan;20(1):97-103. doi: 10.1097/CCO.0b013e3282f310f6.
4
Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.在p53基因缺失的Hep3B肝癌细胞中,pectenotoxin-2诱导细胞凋亡是通过诱导DR4/DR5、Egr-1和NAG-1,激活半胱天冬酶以及调节Bcl-2家族来介导的。
Oncol Rep. 2008 Feb;19(2):517-26.
5
Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer.拮抗癌症中Bcl-2同源物存活功能的小分子BH3模拟物
Curr Opin Investig Drugs. 2009 Jun;10(6):559-71.
6
Apoptosis: future directions in cancer therapy.细胞凋亡:癌症治疗的未来方向
Natl Med J India. 2000 Mar-Apr;13(2):71-8.
7
Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model.以黑色素瘤为模型克服癌细胞对凋亡抗性的当前策略。
Int Rev Cytol. 2006;251:131-58. doi: 10.1016/S0074-7696(06)51004-6.
8
Regulation of death receptors--relevance in cancer therapies.死亡受体的调控——在癌症治疗中的相关性
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):123-32. doi: 10.1016/j.taap.2005.03.032.
9
Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.Bcl-2 在肿瘤细胞存活中的作用及其对药物治疗的意义。
J Pharm Pharmacol. 2012 Dec;64(12):1695-702. doi: 10.1111/j.2042-7158.2012.01526.x. Epub 2012 Apr 25.
10
Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.顺铂耐药非小细胞肺癌细胞凋亡信号转导缺陷
Oncol Rep. 2005 Jun;13(6):1229-34.

引用本文的文献

1
The Persistent Power of the Taxane/Platin Chemotherapy.紫杉烷/铂类化疗的持久效力
Cancers (Basel). 2025 Apr 2;17(7):1208. doi: 10.3390/cancers17071208.
2
Terbinafine for prostate cancer: development of coated zein nanospheres for ameliorated pro-apoptosis in PC3 cells.用于前列腺癌的特比萘芬:制备用于改善PC3细胞促凋亡作用的玉米醇溶蛋白包衣纳米球
Nanomedicine (Lond). 2025 Apr;20(8):817-833. doi: 10.1080/17435889.2025.2481823. Epub 2025 Apr 2.
3
The cross-talk between NRF2 and apoptosis in cancer.癌症中NRF2与细胞凋亡之间的相互作用。
Med Mol Morphol. 2025 Mar 24. doi: 10.1007/s00795-025-00434-2.
4
Pyrrole-Tethered Bisbenzoxazole Derivatives: Apoptosis-Inducing Agents Targeting Breast Cancer Cells.吡咯连接的双苯并恶唑衍生物:靶向乳腺癌细胞的凋亡诱导剂。
Chem Biol Drug Des. 2025 Mar;105(3):e70078. doi: 10.1111/cbdd.70078.
5
Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study.通过全转录组关联研究鉴定与睾丸生殖细胞肿瘤易感性相关的基因。
Am J Hum Genet. 2025 Mar 6;112(3):630-643. doi: 10.1016/j.ajhg.2025.01.022. Epub 2025 Feb 24.
6
Probing structural requirements for thiazole-based mimetics of sunitinib as potent VEGFR-2 inhibitors.探究基于噻唑的舒尼替尼模拟物作为强效VEGFR-2抑制剂的结构要求。
RSC Med Chem. 2025 Jan 22. doi: 10.1039/d4md00754a.
7
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication.焦亡与肿瘤微环境中细胞因子的串扰:从机制到临床意义。
Mol Cancer. 2024 Nov 30;23(1):268. doi: 10.1186/s12943-024-02183-9.
8
Historical Perspective and Current Trends in Anticancer Drug Development.抗癌药物研发的历史回顾与当前趋势
Cancers (Basel). 2024 May 15;16(10):1878. doi: 10.3390/cancers16101878.
9
Exploring the apoptotic effects of sericin on HCT116 cells through comprehensive nanostring transcriptomics and proteomics analysis.通过全面的纳米串转录组学和蛋白质组学分析探索丝胶对 HCT116 细胞的凋亡作用。
Sci Rep. 2024 Jan 29;14(1):2366. doi: 10.1038/s41598-024-52789-8.
10
Suppression of Bcl3 Disrupts Viability of Breast Cancer Cells through Both p53-Dependent and p53-Independent Mechanisms via Loss of NF-κB Signalling.抑制Bcl3通过NF-κB信号通路丧失,经p53依赖和p53非依赖机制破坏乳腺癌细胞的生存能力。
Biomedicines. 2024 Jan 10;12(1):143. doi: 10.3390/biomedicines12010143.